多価リガンドアーキテクチャによる受容体-リガンド結合機構に影響を与える
Jason E Gestwicki1, Christopher W Cairo, Laura E Strong
1Departments of Biochemistry and Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Journal of the American Chemical Society
|December 12, 2002
まとめ
リンガンド構造が生物学的機能を決定する. 研究者らは,多価結合体構造が,受容体結合とクラスタリングを変化させ,生物学的プロセスに影響を与えることによって,阻害体または効果体として作用するかどうかを決定することを発見しました.
科学分野:
- バイオケミストリー バイオケミストリー
- 化学生物学 化学生物学とは
- 分子相互作用とは
背景:
- 多価リンガンドは,受容体相互作用を通じて生物学的プロセスを調節する.
- リガンド受容体結合親和性は抑制に影響を及ぼし,受容体クラスタリングはエフェクタ機能に影響する.
- インヒビターとエフェクターの役割を決定する分子特性は,まだ十分に理解されていません.
研究 の 目的:
- 生物学的活動に多価結合体構造がどのように影響するかを調査する.
- 多様なリガンドを合成し,受容体阻害とクラスタリングに与える影響を評価する.
- リガンドの設計と特定の結合機構の関係を解明する.
主な方法:
- 構造的に多様な28の多価リガンドを合成した.
- スキャフォルドの形状,サイズ,バレンシー,結合要素の密度の影響を調査した.
- コンカナヴァリンA (Con A) を阻害およびクラスタリングアッセイのモデルタンパク質として利用した.
主要な成果:
- リガンドの構造は,リガンドが受容体を阻害するか,クラスタリングするかを決定する.
- 高分子量,多分散リガンドは,Con A結合を効果的に阻害する.
- 線形オリゴメリックリガンドは受容体クラスタリングを促進し,形状はクラスタリングのダイナミクスを影響する.
結論:
- 多価リガンド構造は,阻害体対効果体機能の決定的決定因子である.
- リガンドの設計を調整すると,特定の生物学的活動を持つ分子が生成されます.
- 多様性指向の合成とターゲティングアッセイは,メカニズム固有のリガンドの開発の鍵です.
さらに関連する動画
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
10:59Visualizing the Conformational Dynamics of Membrane Receptors Using Single-Molecule FRET
Published on: August 17, 2022
関連する概念動画
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
